...
首页> 外文期刊>Pathology oncology research: POR >p16INK4a Immunoprofiles of Squamous Lesions of the Uterine Cervix–Implications for the Reclassification of Atypical Immature Squamous Metaplasia
【24h】

p16INK4a Immunoprofiles of Squamous Lesions of the Uterine Cervix–Implications for the Reclassification of Atypical Immature Squamous Metaplasia

机译:p16INK4a子宫颈鳞状病变的免疫学特征-对不典型鳞状上皮化生的重新分类的意义

获取原文
           

摘要

p16INK4a immunoprofiles of non-precancerous and dysplastic squamous cervical lesions were defined and applied to the reclassification of atypical immature squamous metaplasia (AIM). The immunoexpression of cytokeratin 17 (CK 17) in AIM was also evaluated. Totally, 295 cervical cone biopsies representing squamous metaplasia, reactive changes, koilocytosis, flat condyloma, CIN I, CIN II, CIN III and AIM were subjected to p16INK4a immunohistochemistry. AIM cases were analyzed using CK 17 antibody. Typical p16INK4a immunoprofiles for the metaplastic, LSIL/HPV and HSIL phenotypes were recorded and used for the categorization of AIM into particular phenotype groups. Results were correlated with CK 17 immunoexpression. All CIN II and CIN III lesions, all but one case of CIN I and all flat condylomas overexpressed p16INK4a. Other non-precancerous lesions, including koilocytosis, were predominantly negative. Contrary to the sporadic and focal immunostaining, diffuse positivity was associated with the dysplastic features of the lesion. CIN II and CIN III were characterized by a diffuse, strong/weak, full-thickness staining, whereas CIN I showed a heterogeneous diffuse/focal, weak/strong, lower half positivity. One third of AIM lesions may be reclassified as HSIL, one third as LSIL/HPV and one third shows metaplastic phenotype. All AIM cases with metaplastic and LSIL/HPV phenotypes expressed CK 17 diffusely, whereas focal positivity slightly prevailed in AIM with HSIL phenotype. We conclude that p16INK4a immunohistochemistry is a supporting method for the differential diagnosis of cervical lesions, which may be especially useful for the reclassification of AIM. The efficacy of CK 17 immunohistochemistry seems to be controversial for these purposes.
机译:定义了p16 INK4a 非癌前和增生性鳞状宫颈病变的免疫特征并将其用于非典型未成熟鳞状上皮化生(AIM)的重新分类。还评估了AIM中细胞角蛋白17(CK 17)的免疫表达。总共对295例代表鳞状上皮化生,反应性改变,小细胞增多,扁平尖锐湿疣,CIN I,CIN II,CIN III和AIM的宫颈活检组织进行了p16 INK4a 免疫组织化学分析。使用CK 17抗体分析了AIM病例。记录化生,LSIL / HPV和HSIL表型的典型p16 INK4a 免疫谱,并将其用于将AIM分为特定表型组。结果与CK 17免疫表达相关。所有的CIN II和CIN III病变,除1例CIN I和所有扁平con突外均过表达p16 INK4a 。其他非癌前病变,包括白细胞增多症,主要为阴性。与偶发性和局灶性免疫染色相反,弥漫性阳性与病变的异常增生有关。 CIN II和CIN III的特征是弥散,强/弱,全厚度染色,而CIN I则表现出异质的弥散/焦点,弱/强,下半正。 AIM病变的三分之一可被重分类为HSIL,三分之一被分类为LSIL / HPV,而三分之一则表现为化生表型。所有具有化生和LSIL / HPV表型的AIM病例均表达CK 17弥漫性,而具有HSIL表型的AIM中病灶阳性稍占优势。结论:p16 INK4a 免疫组化是宫颈病变鉴别诊断的一种辅助方法,可能对AIM的重新分类特别有用。出于这些目的,CK 17免疫组织化学的功效似乎是有争议的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号